Who
Lisa Cabott Carson
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Phio Pharmaceuticals.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Sep 2025
- Last trade
- 28 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Sep 2026filed 29 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —108,000 at $0.00 | filing |
| 28 Sep 2026filed 29 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —108,000 at $0.00 | filing |
| 11 Sep 2026filed 15 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $13K12,888 at $1.03 | filing |
| 11 Sep 2026filed 15 Sep 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $13K12,888 at $1.03 | filing |
| 5 Feb 2026filed 6 Feb 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —47,000 at $0.00 | filing |
| 5 Feb 2026filed 6 Feb 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —47,000 at $0.00 | filing |
| 11 Sep 2025filed 15 Sep 2025 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —47,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.